AT-007

CAS No. 2170729-29-8

AT-007( —— )

Catalog No. M23983 CAS No. 2170729-29-8

AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 120 In Stock
5MG 107 In Stock
10MG 180 In Stock
25MG 330 In Stock
50MG 523 In Stock
100MG 728 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AT-007
  • Note
    Research use only, not for human use.
  • Brief Description
    AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM).
  • Description
    AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM). It reduces toxic galactitol levels and prevents disease complications in GALT deficiency rats.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Reductase
  • Recptor
    Aldose Reductase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2170729-29-8
  • Formula Weight
    425.4
  • Molecular Formula
    C17H10F3N3O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:35.71 mg/mL (83.94 mM; Need ultrasonic)
  • SMILES
    OC(CC(c1cscc11)=NN(Cc2nc(cc(C(F)(F)F)cc3)c3s2)C1=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Maeve Conneighton, et al. Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in Galactosemia.
molnova catalog
related products
  • PHA767491 HCl

    PHA-767491 is an effective ATP-competitive dual Cdc7/CDK9 inhibitor (IC50: 10/34 nM).

  • Isoliquiritigenin

    Isoliquiritigenin, an anti-tumor flavonoid from the root of Glycyrrhiza glabra, inhibits aldose reductase with an IC50 of 320 nM.

  • Sulindac sulfone

    Sulindac sulfone is a metabolite of the nonsteroidal anti-inflammatory drug sulindac. Sulindac sulfone is an inhibitor of aldose reductase (IC50 =367 nM).